MedPath

Text Message Support to Prevent Smoking Relapse

Not Applicable
Completed
Conditions
Tobacco Use Disorder
Registration Number
NCT02968095
Lead Sponsor
Miami University
Brief Summary

The purpose of this research is to test a text message intervention for people who are beginning an attempt to quit smoking. The intervention seeks to teach people to think about their cravings to smoke in more helpful ways. The investigators expect that participants receiving the text message craving program will be less likely to begin smoking again compared to participants in a control condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Age 18 or older
  • Current daily smoking defined as smoking ≥5 cigarettes per day and having smoked for at least 3 months. During the first visit smoking status will be verified by a Carbon Monoxide level of at least 8 parts per million.
  • Have a mobile phone and use text messaging at least monthly
  • Be planning to quit smoking without pharmacological help.
Exclusion Criteria
  • Significant cognitive impairment
  • Current therapy or pharmacological intervention for smoking or nicotine cravings
  • Inability to read English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
7-Day Point Prevalence AbstinenceEnd of Treatment (6-week) Follow-Up

Point prevalence abstinence is defined as the prevalence of not experiencing a full relapse in the period immediately preceding measurement. A full relapse will be defined as 7 continuous days of smoking or smoking ≥ 1 day(s) per week for the two consecutive weeks preceding the time of measurement. Self-reported abstinence will be verified by a Carbon Monoxide assay of breath samples and will override self-report in the direction of smoking.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Miami University

🇺🇸

Oxford, Ohio, United States

Miami University
🇺🇸Oxford, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath